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Introduction
Headaches without adequate structural damage, predomi-
nantly tension headache and migraine, are a major cause
of loss of productivity [1] and health expenditure. The
medical sciences of our times (and of the last 300 years)
have so far not found a plausible way to account for these
disorders of otherwise healthy persons of all ages, consti-
tutions and social situations. Headache problems have
been relegated among the so-called civilisation diseases,
which means that deficient habits and faulty ways of life,
and ultimately, sin would be responsible, but history [2]
shows that problematic headache was at least as important
in ancient societies as it is today, and geographic differ-
ences are too vague to interpret because of widely diver-
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Abstract We assessed demograph-
ics, diagnoses, course, severity,
impact and treatment of primary
headache outpatients from records
in the Headache and Pain Clinic,
Neurological Department, Zürich
University Hospital. All outpatients
seen from 1996 to 1998 for
migraine, tension-type headache,
and both, were included.
Diagnoses, drug, physical and alter-
native treatments before and after
referral were listed. Descriptive sta-
tistics were used for differences
between the general population and
this sample, the diagnoses, and
treatments. The coexistence of
migraine and tension-type
headache, and the high frequencies
of headache days would have
excluded most migraine patients
from typical drug trials: at best,
only one third were eligible. The
socioeconomic impact of combined
and difficult syndromes calls for
comprehensive management beyond
simple treatment with instant relief
drugs. The diagnostic and therapeu-
tic practices of referring physicians
exposed a deficit of information on
headache, and a need for relevant
education.
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gent local conditions and methods. Headache has been a
normal feature of the general human condition (conditio
humana), since its lifetime prevalence is above 95% of the
total population, but problematic headache which afflicts
at least 10% is a disease, and needs to be treated, urgent-
ly, and with adequate know-how.
The Headache and Pain Clinic (HPC) in the Neurology
Department, Zurich University Hospital, is a service for
the assessment and management of difficult headache
problems. Since its beginning in 1966, patients have been
referred by various specialist physicians and surgeons in
various hospitals and in private practice, as well as gener-
al practitioners. Self-referrals, usually upon recommenda-
tion by follow-up patients, have also been accepted. These
patients had usually been treated unsuccessfully by sever-
al physicians and laymen. They required time-consuming,
individualised care. Therefore, systematic review of data
had to be limited to small samples of the clinic population
[3, 4]. Meanwhile Merikangas and co-workers found sur-
prising data on headache and migraine in their Zurich
cohort study [1], where they followed a sample of the gen-
eral population over 20 years. Migraine and tension-type
headache were shown to be major problems in the Zurich
population at large. The need for corresponding larger
studies of the headache clinic population became obvious.
In order to assess the characteristics of the population and
as a preparation for appropriate prospective studies, we
investigated retrospectively a sample of 1625 patients of
our clinic.
Patients and methods
From the files of the clinic we selected those patients with
migraine, tension-type headache and combinations of migraine
and tension-type headache who had been seen in the years
1996–1998 (n=1625). The following data were collected in a
questionnaire designed for this purpose.
Sex, age and native language; marital status; children; edu-
cational status; occupation; referral; diagnosis before and after
referral; age of onset of headache; frequency of headache
(headache days per month); loss of working days per month and
per year; other diseases, and drugs taken for them; special inves-
tigations: CT scan, MRI and EEG before and after referral; long-
term prophylactic drugs for headache before and after referral;
drugs for acute headache (attacks) before and after referral;
drugs discontinued because of adverse effects, or lack of effect;
alternative, or complementary treatment before and after refer-
ral; special remarks.
Where necessary, missing data were obtained by telephone
interview using the same form. However it was not possible to
reach every patient for this purpose. The following data have not
been obtained: onset of headache in 17.9%, education and pro-
fession in less than 5%; absence from school/work in less than
2%; frequency of headaches and marital state in 1%. Missing
data was excluded for the analysis.
Data were analysed using SPSS (version 8.0) and SAS 8.2
for Windows. χ2- and U-tests were used to assess the statistical
significance of differences between headache subtypes.
Results
Demography and clinical characteristics
According to the IHS criteria [5], 47.3% of the patients
had migraines, 20% had tension-type headaches and
32.7% had migraines combined with tension-type
headaches. The distribution of demographic characteris-
tics in this clinical sample (n=1625) was typical of treat-
ment samples: women were over-represented by 72% as
against 28% men, nearly 3:1, the proportion usually found
in migraine. See also Table 1.
The age range of the migraine patients was 8–74 years,
with a mean age of 39.3 years. Tension-type headache
patients were between 7 and 82 years, with a mean age
37.4. The mean age of onset was 20.5 years for migraine
and 30.2 years for tension-type headache (Fig. 1).
On average, migraine patients had a lower frequency of
headache days per month than tension-type headache
patients. There were more patients with less than 4 headache
days per month in migraine (28% as against 5% in tension-
type headache) and more patients with daily headache in
tension-type headache (61% as against 9.3% in migraine). A
large majority of tension-type headache patients had daily
headache (61%). Altogether 82.4% fulfilled the criteria of
chronic tension-type headache. This clearly outweighs the
incidence of chronic tension-type headache found in the
general population of Germany and Denmark (3%) [6, 7].
Nearly one third of all migraine patients fulfilled the
criteria for chronic migraine, whereas in the general
German population only 2% of the migraine sufferers had
15 or more headache days per month [8]. See also Table 2.
Impact
57.8% of 748 patients with migraine, and 83.4% of 314
patients with tension-type headache had no loss of school
or work days. 28.8% of the migraine patients, and 9% of
the patients with tension-type headache had lost up to 30
days per year. 13.4% of the migraine patients, and 7.6% of
the tension-type headache patients reported work loss of
more than one month per year. Some had not been able to
work at all.
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Diagnosis and special investigations
Major differences were encountered in diagnoses and treat-
ment before and after assessment in the headache clinic.
The diagnoses of migraine and that of tension-type
headache were established much more often in the clinic
than by referring physicians. Of headaches finally diag-
nosed as migraine, 57% were referred as migraine, 6% as
tension-type headache with or without migraine and 37%
as headache without further specification. The situation
was even more incongruous in tension-type headache
where 79% were referred as unspecified headache, 17% as
tension-type headache with or without migraine and 4% as
migraine (Fig. 2).
The most frequent special investigations were: CT
scan (18.2% before, 7.6% after first consultation), EEG
(10% before, 2.3% after first consultation) and MRI (5.5%
before, 3.8% after first consultation). No pathology was
found which would have led to further investigations,
interventions or change of treatment.
Table 1 Demographics. Numbers in parentheses are values expected in the population of Switzerland
Women Men Total pFMa
Patients, n 1166 459 1625
Patients, % 71.8 (51.2) 28.2 (48.8) 100
Age distribution (years)
Median age 38 37 38.5 0.16
4–19, % 6.5 7.8 6.9
20–39, % 47.0 51.0 48.1
40–64, % 43.1 37.0 41.4
65–79, % 3.2 3.5 3.6
80–86, % 0.2 0.7 0.4
Marital status 0.005
Single, % 31.8 40.1 34.1 (42.0)
Married, % 54.3 51.1 55.3 (46.6)
Divorced, % 9.6 6.4 8.7 (5.5)
Widowed, % 2.3 0.9 1.9 (5.9)
Education (25–64 years) 0.001
Basic education, % 24.7 (25.7) 12.8 (12.9) 21.3 (19.3)
Trade school, % 68.1 (61.5) 71.0 (54.0) 68.9 (57.8)
Tertiary education, % 7.2 (12.8) 16.2 (33.1) 9.8 (22.9)
Foreign language speakers 34.1 39.4 34.6 (19) 0.05
aU-tests and χ2-tests, respectively, comparing females vs. males
Fig. 1 The age of onset-curve has a sharp
peak at 13 years in the migraine group
(puberty, prepuberty)
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Treatment before and after first consultation in the HPC
See Table 3. Monotherapy was the exception both before
referral and in HPC prescriptions (altogether 64). The main
difference between treatment by referring doctors and treat-
ment in the HPC was a shift from instant relief drugs to pro-
phylactics, especially to magnesium (new: 1062), antide-
pressants (691) and beta-blockers (461). There was a modest
decrease of ergotamines, matched by a comparable increase
of triptans. However most patients kept the instant relief
drugs they were using, usually declaring that they helped
them best of all, independent of their pharmaceutical nature.
Previous alternative or complementary treatment
(acupuncture, aromatherapy, Atlaslogy, Bach flowers, bio-
resonance, china oil, chiropractic, colour therapy, cran-
iosacral therapy, electrotherapy, foot reflex massage,
homeopathy, laser treatment, lymph drainage, magnetopa-
thy, morphology, neural therapy, neurolinguistics,
osteopathy, phytotherapy, psychophony, Reiki, Shiatsu,
vitalogy, yoga) was reported by 484 patients while 1141
did not report such treatments.
The most frequently reported complementary treat-
ments were acupuncture (338) and homeopathy (120),
while all other methods were reported by small minorities.
Table 2 Characteristics of headache types. Numbers are percentages or medians (with quartiles in parentheses)
Migraine Tension Both
F M pFMa F M pFMa F M pMTa
Patients, n 597 170 – 169 157 – 400 132 –
Patients, % 36.7 10.5 – 10.4 9.7 – 24.6 8.1 –
Age 39 (30–49) 39 (31–47) 0.64 35 (24–50) 34 (26–47) 1.0 36 (26–49) 36 (27–45) 0.002
Age of onset 19 (13–27) 16 (10–29) 0.05 27 (19–42) 26 (20–37) 0.82 17 (12–26) 20 (13–30) 0.001
Frequency
headache 8 (4–14) 6 (4–12.5) 0.04 30 (17.5–30) 30 (16–30) 0.6 18 (9–30) 17.5 (8–30) 0.001
days/month
<4 headache 18.8 25.3 0.06 3.0 7.6 0.06 6.3 6.1 0.001
days/month, %
Daily headache, % 8.2 12.4 0.10 60.4 58.0 0.66 35.3 37.9 0.001
No. school/work 18 (12–48) 13.5 (6–30) 0.20 41 (12–144) 24 (10–48) 0.29 18 (12–42) 18 (12–57) 0.001
days lostb
aU-tests. pFM compares females vs. males; pMT compares migraine vs. tension headache subjects
bOnly subjects who have had any absences are considered
Fig. 2 More than one half of the migraine
group were referred as migraine but only one
sixth of the tension-type headaches, and one
tenth of the combined headaches came in with
a correct diagnosis. Most of the headaches
were referred as “unspecific headache”
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Discussion
Demography and clinical characteristics
Compared to the general population of Switzerland in
1998 [9] there was a preponderance of the age group from
20 to 65 years (89% against 61.6%). Severe headache
problems appear to prevail in the middle age groups
where workload, family stresses and competition are more
likely to become unbearable. The marital status of the
patients presented no important differences to the distrib-
ution in the general population.
The educational characteristics showed no over-repre-
sentation of higher learning, contrary to the popular prej-
udice about migraine as a disease of intellectuals. The per-
centage of patients with tertiary education was only half
of that found in the general population [9]. As more than
one third of all patients were native speakers of other lan-
guages than the official German of the region of Zürich,
this permits us to infer that those with a socially under-
privileged status may be over-represented in this sample.
Although the onset of migraine in our sample was 10
years lower than the onset of tension-type headache, the
patients in the migraine group were on average 2 years
older than the tension-type headache patients. This could
imply a longer duration of the migraine disease.
There were abundant differences in the frequency of
headache of our population compared to epidemiological
data from Germany and Denmark. Chronic tension-type
headache was over-represented nearly 24 times, and
chronic daily headache combined with migraine, though
non-existent in the published German data, was found in
nearly 10% of the migraine patients, while 29.6% had 15
or more headache days per month. This could well be
explained with very frequent headaches as a motive for
seeking professional help.
We applied the selection criteria from the revised IHS
guidelines for controlled trials of drugs in migraine [10]. A
maximum of 390 of 1299 (30%) patients with migraine or
migraine and tension-type headache would be eligible for
trials with acute or prophylactic drugs, due to the high
migraine frequency. Further need for medical treatment may
be greatest where the selection criteria of the IHS guidelines
for migraine drug trials [10] will be least applicable.
Impact
Only one third of the whole group reported loss of work
or school days. As there were altogether 1166 women,
more than half of them without gainful occupation, and
more or less able to wait at home for the end of a bad
headache attack or a bad headache episode, the present
reports are showing only part of this problem. Merikangas
and co-workers [1] found up to 90% impairment of social
and leisure activities, and up to 75% occupational impair-
ment in the migraine sufferers among the high-risk group
of the Zurich cohort study.
Table 3 Drug treatment before and after initial consultation at HPC (number of drugs taken by the 1625 patients, often more than one by
each patient)
Previous (stopped) Continued at HPC HPC prescribed (new)
Acute type
Benzodiazepines 12 3 2
Ergotamines 456 402 141
Opioids 45 19 8
Simple analgesics 784 1234 417
Combined analgesics 186 202 24
Triptans 114 139 224
Prophylactic type
Anticonvulsants 26 3 30
Antidepressants* 193 104 691
Benzodiazepines 28 3 3
Beta blockers 239 67 461
Calcium antagonists 360 22 325
Ergotamines 295 16 49
Magnesium 29 85 1062
Serotonin antagonists** 16 3 11
*Tricyclics and serotonin reuptake inhibitors (SSRIs)
**Methysergide and pizotifen
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According to the IHS criteria [5] and definitions the
intensity of tension-type headache should not be severe,
that is, not severe enough to block the usual daily activi-
ties. Contrary to these expectations 16.6% of our tension-
type headache patients reported loss of work days, as
against 42.2% of the migraine patients, which is more in
keeping with the migraine criteria defining attacks of
moderate to severe headache. In a sizeable minority, dis-
ability occurred on more than 30 days per year: 11.3% of
all patients, 13.4% of those with migraine and 7.6% of
those with tension-type headache. These severe problems
may be concentrated in the specialist clinic but they are
closely related to the encroachment on the quality of life
in the general population [1].
Treatment
Treatment before and after HPC prescriptions was usually
drug treatment, predominantly using more than one drug,
combining at least one prophylactic and one instant relief
type drug. Previous treatment consisted mostly of instant
relief drugs, whereas the HPC preferred prophylactic
drugs for treatment. The salient feature was the change
from 29 patients taking magnesium previously to 1062
who had it prescribed at HPC (85 continuing from before).
Similar but lower increases were observed in antidepres-
sants (193 to 691, 104 continuing) and beta-blockers (239
to 461, 67 continuing). The increase in beta-blockers was
associated with a shift from propranolol to nadolol. In 315
cases flunarizine was stopped and cyclandelat was newly
prescribed in 260 patients. Both these changes were
intended for better tolerability.
Among the instant relief drugs, simple analgesics
showed both the highest number of users and the highest
continuity of use, with similar patterns but lower numbers
for ergotamine compounds and triptans. Opioids and benzo-
diazepines were only used by marginal minorities. One third
reported various complementary or alternative treatments.
Conclusions
The typical patient at the Headache and Pain Clinic is a
35-year-old married woman with both migraine without
aura and tension-type headache with a frequency of 15
headache days per month, resulting from both syndromes.
Age distribution of migraine and tension headache
patients appears to be different and typical for each syn-
drome. The findings are more compatible with a continu-
ous spectrum of primary headache syndromes than with
the concept of neatly separate nosological entities, which
is in turn hardly compatible with clinical experience
where replacement or transformation of tension-type
headache by or into migraine, and vice versa, is reported
by a very important minority of patients.
The most striking difference was found between diag-
noses by referring physicians and diagnoses established in
the clinic. Over 80% of tension-type headaches, and over
one third of migraines diagnosed in the clinic had been
referred with unspecified headache diagnoses.
Patients referred to the headache clinic reported med-
ication closely resembling that of the epidemiological
studies of Isler et al. [11] in the region of most frequent
referral, the Canton of Zürich and its surroundings. This
consisted mainly of analgesics for acute attacks, some-
times overused. Prophylactics were applied rarely and
rather indiscriminately, often without consideration of
their specific indication for migraine.
As a whole, our study indicated that availability of
information on current diagnosis and treatment, as it were,
is still insufficient in referring general practitioners.
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